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Thyroid hormone (TH) is essential for adult brain function and its actions include several key roles in the hypothalamus.
Although TH controls gene expression via specific TH receptors of the nuclear receptor class, surprisingly few genes have
been demonstrated to be directly regulated by TH in the hypothalamus, or the adult brain as a whole. This study explored
the rapid induction by TH of retinaldehyde dehydrogenase 1 (Raldh1), encoding a retinoic acid (RA)-synthesizing enzyme, as a
gene specifically expressed in hypothalamic tanycytes, cells that mediate a number of actions of TH in the hypothalamus. The
resulting increase in RA may then regulate gene expression via the RA receptors, also of the nuclear receptor class. In vivo
exposure of the rat to TH led to a significant and rapid increase in hypothalamic Raldh1 within 4 hours. That this may lead to
an in vivo increase in RA is suggested by the later induction by TH of the RA-responsive gene Cyp26b1. To explore the
actions of RA in the hypothalamus as a potential mediator of TH control of gene regulation, an ex vivo hypothalamic rat slice
culture method was developed in which the Raldh1-expressing tanycytes were maintained. These slice cultures confirmed that
TH did not act on genes regulating energy balance but could induce Raldh1. RA has the potential to upregulate expression
of genes involved in growth and appetite, Ghrh and Agrp. This regulation is acutely sensitive to epigenetic changes, as has
been shown for TH action in vivo. These results indicate that sequential triggering of two nuclear receptor signalling systems
has the capability to mediate some of the functions of TH in the hypothalamus.
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Introduction
Thyroid hormones (TH) act to control gene expression bybinding and activating specific nuclear receptor family
transcription factors. TH is known to regulate energy balance
and metabolism, with actions in both peripheral tissues and in
the brain (reviewed by Lechan and Fekete, 2006; Lopez et al.,
2013). Increased food intake (hyperphagia) is a characteristic
symptom of hyperthyroidism, the overproduction of TH. This
is generally believed to result from increased energy expenditure
in peripheral tissues, but some hyperthyroid patients increase
their food intake enough to gain weight (Gurney et al., 1970),
suggesting that it is not simply a compensatory change. TH sig-
nalling may be important to initiate the drive to feed as deiodi-
nase 2, the enzyme that activates TH signalling by converting
thyroxine (T4) into the transcriptionally more active triiodo-
thyronine (T3), is upregulated by fasting in the hypothalamus
(Diano et al., 1998), the region of the brain controlling feeding,
growth, and reproductive status. Moreover, acute and chronic
administration of low doses of T3 has been shown to increase
feeding without affecting energy expenditure (Kong et al.,
2004). These observations suggest that TH has central, as well
as peripheral effects on the regulation of feeding behavior and
metabolic states. Hyperthyroid rats show an upregulation of the
orexigenic gene agouti-related protein (Agrp) in the hypothala-
mus accompanied by a decrease in proopiomelanocortin (Pomc),
the precursor of the anorexigen alpha-melanocyte-stimulating
hormone (a-MSH; Varela et al., 2012). In addition, the impor-
tance of TH signalling in the hypothalamus is highlighted in
the regulation of energy balance of seasonal animals (Barrett
et al., 2007). This highly conserved pathway is now considered
to be the basis of long-term changes in energy balance, growth
and reproduction, in birds and mammals. In Siberian hamsters,
hypothalamic implants releasing T3 promote long day-like (i.e.
summer-like) reproductive and body weight responses (Murphy
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et al., 2012) and conversely local delivery of T3 is able to block
short day (winter-like)-induced weight loss (Barrett et al.,
2007). From these findings it is now generally concluded that
local hypothalamic T3 availability is responsible for long-term
seasonal changes in energy metabolism.
The observations described above suggest that TH signal-
ling is an important regulator of hypothalamic function. TH is
thought to control genes affecting growth and energy balance in
seasonal mammals including Agrp, Ghrh, and Pomc (Ross et al.,
2009), although this control may be indirect. However despite
considerable investigation, the genes directly regulated by TH
in the hypothalamus are largely unknown; indeed, the genes
regulated by TH in much of the brain remain undiscovered.
Retinaldehyde dehydrogenase 1 (Raldh1, also known as
Aldh1a1) is regulated by a number of hormone activators of
nuclear receptors, such as estrogen (Fujiwara et al., 2009) and
androgen (MacLean et al., 2008), as well as metabolite-
regulated nuclear receptors such as LXR (Huq et al., 2006). Via
its synthesis of retinoic acid (RA) from retinaldehyde, Raldh1
itself then controls the activity of further nuclear receptors, the
retinoic acid receptors (RARs). In the hypothalamus, Raldh1 is
specifically localized to tanycytes, radial glia-like cells lining the
third ventricle, potentially acting to communicate between the
cerebrospinal fluid, circulation, and hypothalamic neurons
(Shearer et al., 2010). They have an intermediary role to play in
the control of appetite and energy balance (Bolborea and Dale,
2013) and help to mediate molecular exchange between blood,
brain, and cerebrospinal fluid (Langlet et al., 2013), including
transport of leptin (Balland et al., 2014). Raldh1 was explored
in vivo as a TH-regulated gene in the rat hypothalamus and was
found to be rapidly induced and potentially under direct TH
control. Gene regulation by RA was studied in an organotypic
slice culture system developed for this study. This system was
free of secondary in vivo influences but maintained the struc-
tures necessary for hypothalamic function. It was shown that
RA regulates the expression of hypothalamic genes known to
affect energy balance and growth and may act as an intermedi-
ary in the action of TH in the hypothalamus. Further, it was
demonstrated that Rarb and Ghrh were epigenetically repressed
and the RA signalling pathway may be a means of epigenetic
control of gene expression in the hypothalamus.
Materials and Methods
Animals
Sprague Dawley rats were bred in the University of Aberdeen animal
facility. Fischer F344/N male rats were supplied by Harlan Sprague
Dawley Inc. (Indianapolis, USA). All animals were kept in a
12h:12h light:dark cycle with unlimited access to food and water.
All procedures conformed to Home Office regulations and local
ethics committee guidelines.
T3 Administration
T3 (Sigma Aldrich) was dissolved in 1 N NaOH at 1 mg/ml and
then diluted to 40 mM in phosphate-buffered saline (PBS), pH 7.4.
Eight-week-old male Sprague Dawley rats were injected subcutane-
ously with 65 mg/kg (100 nmol/kg) T3. Control animals were
injected with an equivalent volume of 1 N NaOH diluted in PBS. 4
hours post-injection, the animals were killed and the hypothalami
were dissected and rapidly frozen on dry ice.
Nissl Staining
Male rat pups were transcardially perfused with saline followed by
4% paraformaldehyde (PFA) in phosphate buffer. The brains were
removed and incubated overnight at 48C in 4% PFA, washed in
PBS and transferred to 30% sucrose in PBS. 40 mm-thick coronal
brain sections were cut using a cryostat, mounted on polylysine-
coated slides, and allowed to dry. Tissue sections were stained with
cresyl violet, dehydrated through an ethanol series into xylene, and
mounted with DPX (Fisher Scientific).
Hypothalamic Organotypic Slice Cultures
To exclude circadian-driven changes in gene expression, all hypo-
thalamic slice cultures were set up at the same time of day (com-
mencing at ZT07-8). P10-12 male rat pups were euthanized with
Euthatal. The brains were removed under sterile conditions and
placed in ice-cold slice culture medium consisting of 50% minimal
essential medium, 25% Hank’s buffered salt solution, 25% heat-
inactivated horse serum, containing penicillin-streptomycin and Glu-
tamax, supplemented with 5 mg/ml additional glucose and buffered
with 25 mM HEPES. The cortices were removed and the brains
were sliced into 400 mm coronal sections using a McIlwain tissue
chopper. Slices were transferred into cold medium, separated using
forceps under a dissection microscope and slices containing the third
ventricle were isolated. Each hypothalamus yielded five to six slices.
The slices were trimmed and cut in half along the midline, giving
two sets of slices per animal, with each containing the same (but
alternate) regions. Each sample consisted of one set of slices. After
incubation in ice-cold culture medium for 1 to 2 hours, each set of
slices was transferred onto a Millicell-CM cell culture insert (Milli-
pore) in a six-well plate using a sterile glass pipette. Excess medium
was removed from the tissue and 1 ml of fresh slice culture medium
was added below the insert. Slices were transferred to 358C, 5%
CO2. After 24 hours, the medium was removed and replaced with
serum-free, vitamin A-deficient medium consisting of Neurobasal
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medium containing B27 supplement without vitamin A, penicillin-
streptomycin and Glutamax (all reagents from Invitrogen) and
5 mg/ml additional glucose. Slices were incubated at 358C, 5% CO2
for a further 3 days. Slices were maintained in vitamin A-deficient
medium to deplete the tissue of retinol and minimize retinoic acid
synthesis by endogenous Raldh1.
The medium was replaced with fresh serum-free, vitamin A-
free medium and slices were treated with 10 mIU bovine thyroid-
stimulating hormone (TSH), 50 nM T3, 10 nM, or 1 mM all-trans-
RA (all from Sigma Aldrich), 50 ng/ml trichostatin A (Cayman
Chemical Co.) or 100 mM sirtinol (Tocris). Sirtinol, retinol and RA
were dissolved in DMSO and therefore an equivalent volume of
DMSO (0.1%) was added to wells containing control slices. One set
of slices from each animal was treated with the other set being used
as control. Treatment times are indicated in figure legends. After
treatment, slices were fixed in 4% paraformaldehyde for 2 hours at
room temperature for immunohistochemistry or excised from the
culture inserts, transferred to microcentrifuge tubes and frozen rap-
idly on dry ice for RNA extraction.
Slice Immunohistochemistry
After 6 days ex vivo, hypothalamic slices were washed with PBS and
fixed by immersion in 4% PFA for 2 hours at room temperature.
Slices were labeled using antibodies against vimentin (V9, Sigma
Aldrich) and Darpp-32 (19A3, Cell Signaling) and appropriate fluo-
rescent secondary antibodies (Jackson ImmunoResearch). The mem-
branes carrying the slices were transferred onto microscope slides
and mounted using mounting medium containing Hoechst. Label-
ling was visualized by fluorescence microscopy.
Primary Tanycyte Culture
Primary tanycyte cultures were prepared from 10-day-old male
Sprague Dawley rat pups as previously described (Bolborea et al.,
2015; De Seranno et al., 2004; Prevot et al., 2003). Brains were
removed under sterile conditions, placed in ice-cold DMEM/F-12
medium containing penicillin/streptomycin and 25 mM HEPES and
the median eminence dissected. Median eminences from 8–10 pups
were pooled together, dissociated and plated out in DMEM/F-12
containing 10% foetal calf serum and penicillin/streptomycin in a
25 cm2 cell culture flask. Medium was replaced every 3 days. The
composition of primary tanycyte cultures was assessed after 8 to 10
days in vitro by immunohistochemistry for the tanycyte marker
vimentin and the astrocyte marker GFAP; all cells expressed vimen-
tin, but only a small number expressed GFAP. RNA was also
extracted from cultured cells and tested by PCR for expression of
the tanycyte markers Dio2, Darpp32, Rax, Tshr, and Gpr50.
Primary cultured tanycytes were transferred to 12-well plates
for experiments after 8-10 days in vitro. The day after plating out,
tanycytes were treated with 50 nM T3 or vehicle for 24 hours. RNA
was extracted from treated cells for qPCR analysis.
Quantitative Polymerase Chain Reaction
Total RNA was extracted from slices using a Qiagen RNeasy RNA
purification kit. cDNA was synthesized from 500 ng total RNA
using High Capacity RNA-to-cDNA Master Mix (Applied Biosys-
tems Ltd). Dio2 and Dio3 primers were obtained from Qiagen
(QuantiTect Primer Assays Rn_Dio2_2_SG and Rn_Dio3_1_SG,
respectively); other primers (Table 1) were designed using Primer-
BLAST (Ye et al., 2012). qPCR reactions were set up using Sensi-
Mix SYBR master mix (Bioline) and were run on a Roche
LightCycler 480 and analysed using LightCycler 480 1.5 software.
Expression of genes of interest was normalized to Actb levels. Stand-
ard curves and blank controls were run for all sets of primers.
Results shown are from a minimum of two independent experiments
per condition. Gene expression in T3-injected rats was compared to
that of vehicle-injected controls using unpaired Student’s t-tests.
Expression in treated hypothalamic slices was compared to control
slices from the same individuals by paired Student’s t-tests or
ANOVA.
Results
Peripheral Administration of T3 Upregulates
Hypothalamic Raldh1 Expression
Thyroid hormone signalling in the hypothalamus is thought
to play a crucial role in the control of energy balance, but lit-
tle is known about its direct targets in the hypothalamus. To
investigate potential targets of TH signalling in the hypothal-
amus, male Sprague Dawley rats were given a single subcuta-
neous injection of 100 nmol/kg T3 at 8 weeks of age.
Treated rats were killed 4 hours post-injection and the hypo-
thalami were rapidly removed for qPCR analysis of hypo-
thalamic genes known to affect energy balance.
Deiodinase 3 (Dio3) has previously been shown to be
directly induced by T3 (Barca-Mayo et al., 2011; Bianco
et al., 2002) and was used as a positive control. Dio3 was
strongly upregulated in the hypothalamus of T3-treated rats
(Fig. 1A), confirming that peripheral administration of T3
increased hypothalamic T3 and that the time between admin-
istration and dissection was sufficient for alterations in hypo-
thalamic gene expression. Despite the presence of T3 in the
hypothalamus, no significant changes in the expression of
agouti-related protein (Agrp), growth hormone-releasing hormone
(Ghrh), neuropeptide Y (Npy), cocaine- and amphetamine-
regulated transcript (Cart) or proopiomelanocortin (Pomc) were
observed in T3-treated animals after 4 hours (Fig. 1A).
Raldh1, which encodes the RA synthetic enzyme retinal-
dehyde dehydrogenase 1 present in tanycytes (Shearer et al.,
2010), was investigated as a gene regulated by several nuclear
receptor family members (Fujiwara et al., 2009; Huq et al.,
2006; MacLean et al., 2008). This gene was significantly
upregulated in the hypothalamus of T3-treated rats (Fig. 1A).
In addition, a sequence with high similarity to a DR4-type
TH response element (TRE; AGCTCAgtcaAGGTGA; Fig.
1B) was identified in the promoter of the rat Raldh1 gene,
close to the transcription start site. The upregulation of
Raldh1 just 4 hours after T3 administration and the presence
of a potential TRE in the promoter of the rat Raldh1 gene
Stoney et al.: Sequential Nuclear Receptors Activation in Tanycytes
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suggest that Raldh1, and so RA synthesis, may be a direct tar-
get of TH signalling in the hypothalamus.
Cultured Hypothalamic Slices with Tanycytes Are
Responsive to Thyroid Stimulating Hormone
The function of T3 and RA in the hypothalamus was further
explored using an ex vivo organotypic culture system. This
technique was modified from that of House et al. (1998) and
allowed T3 and RA to be studied independently of feedback
from the rest of brain or body. The brain was removed from
P10-12 male Sprague Dawley rat pups and cut into 400 mm-
thick coronal slices. Slices were trimmed dorsally at the level
of the mammillothalamic tract and laterally at the fornix,
both of which were visible in the slices (Fig. 2A, B). These
slices contained the ventricular region and median eminence
(ME) in addition to the arcuate (ARC), ventromedial
(VMN), dorsomedial (DMN), and paraventricular (PVN)
hypothalamic nuclei. Trimming the slices using visible ana-
tomical cues minimized variation but allowed for differences
in brain size between individual animals. The slices were
standardly cultured in serum-free vitamin A-free medium for
72 hours before treatment, depleting the tissue of vitamin A
and thereby preventing endogenous synthesis of retinoic acid.
Crucially for these studies, these slices could be cultured
in a way that maintained health of the neurons, the integrity
of the hypothalamic nuclei and also the viability of cells vital
to TH and RA signalling, the tanycytes. The tanycytes are
specialized radial glia-like cells in the cell layer lining the
third ventricle thought to be critical for the transduction of
extrahypothalamic signals into the parenchyma. Tanycytes are
the cells in which both RA is synthesized (Shearer et al.,
2010; Shearer et al., 2012b) and thyroxine (T4) is converted
to the more active T3 (Yasuo et al., 2007). To confirm the
presence of tanycytes in cultured rat hypothalami, slices were
maintained ex vivo for 6 days and then fixed in 4% PFA.
Immunohistochemistry using antibodies against the tanycyte
markers vimentin (Fig. 2C-E; Leonhardt et al., 1987) and
dopamine- and cAMP-regulated phosphoprotein (DARPP-32,
Fig. 2F-H; Meister et al., 1988) demonstrated that tanycytes
were present after 6 days of ex vivo culture, with processes
projecting into the parenchyma of the hypothalamus.
Short-term slice cultures of adult mouse hypothalamus
have been shown to be responsive to thyroid-stimulating hor-
mone (TSH) after 4 hours ex vivo, upregulating Dio2 expres-
sion and downregulating Dio3 in the ependymal cell layer of
the ventromedial hypothalamus (Unfried et al., 2009). TSH
was used as a positive control to test the response of tanycytes
in cultured rat slices to a hormonal signal. Slices were main-
tained in culture for 4 days, then treated for 48 hours with
10 mIU bovine TSH before qPCR analysis. TSH treatment
of cultured slices induced a 4-fold increase in Dio2 expression
(P50.005; Fig. 2I) and reduced Dio3 by 95% (P5 0.02;
(Fig. 2J). These data demonstrate that tanycytes are main-
tained in cultured rat hypothalamus for up to 6 days and that
FIGURE 1: T3 upregulates Raldh1 expression in the rat hypothalamus in vivo. A: Eight-week old male Sprague Dawley rats were injected
subcutaneously with 100 nmol/kg T3. The hypothalamus was removed 4 hours after T3 injection for qPCR analysis. Expression of Agrp,
Pomc, Npy, Cart, and Ghrh was unaffected by short-term T3 treatment, but hypothalamic Raldh1 was significantly upregulated 4 hours
after T3 injection, compared with vehicle-injected animals. Dio3 was used as a positive control for the activity of T3. N53 animals per
treatment group. B: A sequence closely matching the consensus sequence of a DR4-type thyroid hormone response element (TRE) was
identified in the rat Raldh1 promoter, suggesting direct regulation of Raldh1 expression by T3. Statistical significance was assessed
using Student’s t-test. ** P<0.01. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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FIGURE 2: Hormone-responsive tanycytes are maintained in hypothalamic organotypic culture. 400 lm coronal slices were cut through
the hypothalamus of P10-12 Sprague Dawley rat pups. The mammillothalamic tract and fornix (A, B) were used as anatomical landmarks
to trim the slices. Nissl staining of P10 rat sections (A) shows the location of the DMN, VMN and arcuate (ARC) nuclei in relation to these
landmarks. Slices fixed after 6 days of culture in vitamin A-deficient medium and labelled using antibodies against the tanycyte markers
vimentin (C–E) and dopamine- and cAMP-regulated phosphoprotein (DARPP-32; F–H) show that tanycytes are present in cultured slices.
To test the response of tanycytes in cultured hypothalamus to hormonal signals, slices were treated with 10 mIU thyroid-stimulating hor-
mone (TSH) for 48 hours before qPCR analysis of gene expression. TSH upregulated Dio2 (I) and downregulated Dio3 (J), demonstrating
that tanycytes are not only present after 6 days ex vivo, but respond as expected to TSH in terms of gene expression. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
cultured tissue can behave like the in vivo hypothalamus in
terms of hormonal control of gene expression.
T3 Upregulates Raldh1 Expression
in Cultured Hypothalamus
A key function for TSH in the hypothalamus is to increase
deiodinase 2 and decrease deiodinase 3 in cells, including
tanycytes, of the ependymal layer of the hypothalamus (Helfer
et al., 2013) and so locally increase T3 levels, the most tran-
scriptionally active form of TH. T3 is known to signal within
the hypothalamus and is essential as a mediator for environ-
mental regulators of growth and energy balance (Mullur
et al., 2014). However, the genes on which T3 directly acts
upon to bring about these changes in the hypothalamus are
poorly understood. Given Raldh1’s induction by T3 in vivo
(Fig. 1A), this was tested in the ex vivo slice culture assay. Sli-
ces were treated with 50 nM T3 for 48 hours before analysis
of gene expression by qPCR.
Raldh1 was potently induced by T3, with a 4-fold
increase in expression in T3-treated hypothalamic slices
(P< 0.001; Fig. 3A), indicating that activation of thyroid
hormone signalling in the hypothalamus itself is sufficient to
upregulate Raldh1 expression and therefore regulate synthesis
of RA in the hypothalamus. Thus, regulation of Raldh1
expression, and therefore potentially the rate of RA synthesis,
in the hypothalamus may provide one route by which T3 can
bring about changes in hypothalamic gene expression.
Induction of Raldh1 was similar to that of the T3 cata-
bolic enzyme Dio3, previously shown to be upregulated by T3
(Bianco et al., 2002) and with a TRE in its promoter (Barca-
Mayo et al., 2011) and which was increased over six-fold in T3-
treated slices compared to controls (Fig. 3B; P5 0.0003). Both
the rat and mouse Raldh1 promoters contain a potential TRE
(Fig. 1B). In contrast, T3 did not significantly alter expression
of Agrp, Ghrh or Pomc, genes thought to be regulated by TH in
vivo in F344 rats (Ross et al., 2009) as part of its action to con-
trol weight and energy balance (Fig. 3A). Similarly, other genes
known to be involved in hypothalamic regulation of these proc-
esses, Npy and Cart, were unaffected by T3 (Fig. 3A).
In vivo, the only cells of the hypothalamus that normally
express Raldh1 are the tanycytes (Shearer et al., 2012b), the
same cells in which T4 is converted to T3 by deiodinase 2
(Dio2). To confirm whether Raldh1 can be induced in tanycytes
by T3, primary tanycyte cultures were established following
previously described protocols (Bolborea et al., 2015; De Ser-
anno et al., 2004; Prevot et al., 2003) which are approximately
95% pure. These cells expressed the typical markers of tanycytes
including Dio3, Vim, Rax, Gpr50 and Darpp-32 (and weakly
Dio2 and Raldh1) by PCR (Fig 3C) and vimentin by immuno-
chemistry (Fig 3D) and T3 was found to significantly induce
Raldh1 by 2.5 fold (P5 0.0020; Fig. 3E).
To investigate whether RA may be synthesized locally in
the hypothalamus by TH-induced Raldh1 the expression of a
gene regulated by RA, and not by TH in the hypothalamus,
was investigated. Cyp26b1 is highly RA-inducible in hypo-
thalamic slices (P5 0.0006; Fig. 4A) but was not induced by
50 nM T3 after 4 or 48 hours (Fig. 4B, D). Weak, although
significant induction is seen after incubation with T3 for 24
hours (Fig. 4C) which may represent a weak response to T3
or possibly may result from low amounts of RA generated
from endogenous retinol in the slices, mediated by T3-
induced Raldh1. In contrast to Cyp26b1, treatment of hypo-
thalamic slices with T3 resulted in robust induction of both
Dio3 (as a positive control; P5 0.025) and Raldh1
(P< 0.0001) in hypothalamic slices after 24 hours (Fig. 4C)
which was maintained at 48 hours (Fig. 4D).
The influence of TH on the same set of genes was then
investigated in vivo. TH rapidly induced both Dio3 and Raldh1
(P5 0.0097 and P5 0.006, respectively; Fig. 4E). This was
faster in vivo than ex vivo, suggesting that culture of slices possi-
bly results in a decline in the speed of tissue responsiveness or
that in vivo TH is perhaps transported or concentrated more
effectively in the hypothalamus, or possibly that extrahypotha-
lamic effects on tanycytes may potentiate Raldh1 expression in
vivo. Cyp26b1 was not induced so rapidly by TH (Fig. 4E) but
significant 2-fold induction was evident by 24 hours
(P5 0.0192; Fig. 4F) following sequentially from the early
increase in Raldh1. This temporal delay in Cyp26b1 induction
would be expected if Cyp26b1 was responding not to exogenous
T3, but to an increase in RA synthesis by Raldh1.
RA Upregulates Growth-Associated Genes
in Cultured Hypothalamus
If RA may act as a downstream mediator of TH’s actions
within the hypothalamus then it would be presumed that RA
may induce some of the growth-associated genes which TH
does not directly control. Hypothalamic slice cultures were
treated with 1 mM RA for 48 hours before qPCR analysis.
Rarb was used as a positive control for RA activity, as its pro-
moter contains a well-characterized RA response element
(RARE; Leid et al., 1992). Rarb expression was 7.8-fold
higher in RA-treated slices than controls (P5 0.004; Fig. 5).
In cultured slices, RA significantly upregulated expres-
sion of the orexigenic gene Agrp (70% increase relative to
control; P5 0.012; Fig. 5) as well as Ghrh (67% increase;
P< 0.001). Npy and Cart expression was unaffected by RA
treatment (Fig. 5). Pomc showed a small but significant
increase in expression in RA-treated slices (27% increase;
P5 0.040). The gene encoding PC2, a prohormone conver-
tase involved in the processing of POMC into hormones
including ACTH and a-MSH (Pritchard et al., 2002), was
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also upregulated by RA treatment (Pcsk2; 32% increase;
P< 0.001).
The experiments described thus far were performed in
hypothalamic slices from outbred Sprague Dawley rats. To
determine if the effects of RA are applicable to multiple
strains of rat, hypothalamic slice cultures were established
using tissue from another commonly used rat strain, the pho-
tosensitive inbred Fischer F344/N. Slices from F344/N rat
pups were treated with 1 mM RA after 4 days ex vivo and
harvested after 48 hours for qPCR analysis (Fig. 6). The
response of F344/N hypothalamic slices to RA was similar to
that of the Sprague Dawley hypothalamus (Fig. 6). As was
observed in Sprague Dawley slices, RA induced significant
upregulation of Rarb (5.96-fold, P< 0.001) and Ghrh expres-
sion (1.80-fold, P5 0.004) in the F344/N hypothalamus.
Smaller but significant increases in the expression of Pomc
(1.40-fold, P5 0.022) were seen with RA. RA treatment of
F344/N hypothalamus increased Agrp expression by a similar
FIGURE 3: T3 upregulates Raldh1 in organotypic cultures of rat hypothalamus. A: Hypothalamic slices from P10 male Sprague Dawley
rats were cultured for 4 days and then treated for 48 hours with 50 nM T3 before qPCR analysis. As in vivo, Raldh1 was upregulated in
T3-treated hypothalamic slices. Agrp, Ghrh, Pomc, Npy and Cart were unaffected by T3. B: Dio3 was used as a positive control for T3
activity. Numbers of samples are shown. C: Primary cultures of tanycytes expressed tanycyte markers Dio3, Vim, Rax, Gpr50 and Darpp-
32. Some markers such as Dio2, were only weakly expressed and this was also the case for Raldh1. D: The cultured tanycytes strongly
expressed vimentin by immunohistochemistry and several of the cells extended long processes. E: Addition of 50nM of T3 to cultured
tanycytes significantly induced their expression of Raldh1. Statistical significance was assessed using paired Student’s t-test. ** P<0.01;
*** P<0.001. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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amount to that seen in Sprague Dawley slices (F344/N: 1.68-
fold increase, P5 0.051; Sprague Dawley: 1.70-fold increase,
P5 0.012), although this increase was not quite significant.
Npy expression was unaffected by RA. Together, these data
suggest that the hypothalamic response to RA treatment is
similar between the two rat strains.
Hypothalamic RA Signalling Is under
Epigenetic Control
Epigenetic regulation of gene expression via DNA/histone
modifications is known to control aspects of hypothalamic
function, such as hormone synthesis (Miller et al., 2011) and
sexual maturation of the brain (Matsuda et al., 2011). In
FIGURE 4: Time course of ex vivo and in vivo induction of genes in the hypothalamus by thyroid hormone. The relative timing of gene
induction by T3 was examined for Dio3, as a positive control Raldh1, the RA synthetic enzyme of the hypothalamus and Cyp26b1, a RA-
responsive gene. Cyp26b1 was demonstrated to respond to RA by direct addition of RA to hypothalamic slices (A). None of the three
genes examined were responsive within 4 hours of addition of T3 to hypothalamic slices (B) but significant increases of both Dio3 and
Raldh1 were evident after 24 (C) or 48 hours T3 treatment (D). Cyp26b1 was only weakly (but significantly) induced at 24 hours (C). In
vivo, Dio3 and Raldh1 were both significantly and rapidly induced by 4 hours (E) and, at least for Raldh1, maintained for 24 hours (F).
Cyp26b1 did not respond as rapidly in vivo but was induced two-fold by 24 hours (F) and thus follows the expression of the Raldh1
gene necessary for RA synthesis. Statistical significance was assessed using unpaired Student’s t-test. * P<0.05; ** P<0.01; ***
P<0.001. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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some cases, this is believed to be a behavioural control mecha-
nism that, for instance, contributes to imprinting action of the
environment on the young animal that results in altered behav-
iour in the mature animal. Epigenetic control via histone acety-
lation is particularly active in promoting RA signalling, and
derepression of RA signalling may be a major rate-limiting tar-
get of histone deacetylase (HDAC) inhibitors (Epping et al.,
2007). To explore whether the RA signalling system in the
hypothalamus is acted upon by such an epigenetic mechanism,
cultured hypothalamic slices were treated with a low concentra-
tion of RA (10 nM) which results in weaker induction of gene
expression. This was combined with trichostatin A (TSA), a
class I/II HDAC inhibitor (HDACI), or sirtinol, an inhibitor
of the sirtuin (class III) family of HDACs.
In cultured slices from F344/N rats, 10 nM RA was suffi-
cient to increase expression of Rarb (2.5-fold increase relative to
controls; Fig. 7A), but not Ghrh (Fig. 7B). TSA alone did not
affect Rarb expression, but potentiated the response to RA (4.1-
fold increase relative to control; 64% higher than RA alone).
Ghrh expression was not altered by 10 nM RA or TSA alone,
but RA and TSA in combination induced a 2.25-fold increase
in Ghrh (Fig. 7B). Sirtinol had no effect on Ghrh expression
FIGURE 5: Retinoic acid regulates expression of Agrp and Ghrh in the rat hypothalamus. Hypothalamic slices from male Sprague Dawley
rats were cultured for 4 days and then treated for 48 hours with 1 lM RA before qPCR analysis. Agrp and Ghrh expression was signifi-
cantly upregulated in RA-treated slices. Pomc and Pcsk2 showed smaller, but still significant increases in expression in RA-treated cul-
tures. Npy and Cart were unaffected by RA treatment. Rarb was used as a positive control for RA activity. Numbers of samples are
shown. Statistical significance was assessed using paired Student’s t-test. * P<0.05; ** P<0.01; *** P<0.001. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 6: The F344/N rat hypothalamus is also responsive to RA. Hypothalamic slices from male F344/N rats were cultured for 4 days
and then treated for 48 hours with 1 lM RA before qPCR analysis. Responses to RA in slices from F344/N rat pups were very similar to
those in Sprague Dawley slices. Ghrh was significantly upregulated in RA-treated slices, with smaller but significant increases in Pomc.
Agrp appeared upregulated to a similar extent to that observed in Sprague Dawley slices (Fig. 4), although this did not reach statistical
significance in this case. Rarb was used as a positive control for the activity of RA. N56 per group for all genes. Statistical significance
was assessed using paired Student’s t-test. * P<0.05; ** P<0.01; *** P<0.001. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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and although the response of Rarb to RA was higher in the pres-
ence of sirtinol (3.3-fold increase relative to controls) than with
RA alone (2.5-fold; Fig. 7A), the difference was not significant.
Expression of Agrp, Pomc and Npy was not significantly altered
by 10 nM RA even in the presence of TSA or sirtinol (Fig. 7C-
E). These data suggest that the expression of some RA-responsive
genes in the hypothalamus may be further regulated as a result of
epigenetic chromatin modifications by class I/II HDACs.
Discussion
TH controls growth-associated physiology but T3, the most
active TH metabolite, does not directly regulate genes involved
FIGURE 7: RA regulation of gene expression in the hypothalamus is subject to epigenetic control by class I/II histone deacetylases. After 4
days ex vivo, F344/N hypothalamic slices were treated for 48 hours with trichostatin A (TSA), a class I/II histone deacetylase inhibitor
(HDACI), or sirtinol, a class III HDACI, in the presence or absence of 10 nM RA. qPCR analysis was performed using primers for Rarb, Ghrh,
Agrp, Npy and Pomc. Rarb was upregulated by 10 nM RA and TSA, but not sirtinol, enhanced the effect of RA (A). Ghrh expression was
significantly upregulated by 10 nM RA only in the presence of TSA (B). Agrp, Npy and Pomc were unaffected by HDACIs (D–E). Numbers
of samples per condition are shown in (A) and were the same for each gene examined. Data were analysed by ANOVA followed by Tukey’s
post hoc tests. ** P<0.01; *** P<0.001. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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in this process and gene targets of TH in the hypothalamus
have proved enigmatic (Barrett et al., 2007). This study shows
that, in vivo, T3 very rapidly induces expression of a key
enzyme, Raldh1, required for RA synthesis by tanycytes, the
source of RA for the hypothalamus (Shearer et al., 2010). That
RA levels rise in the hypothalamus on addition of TH is sug-
gested by the induction of a RA reporter gene, Cyp26b1, a
gene relatively refractory to TH. An organotypic culture system
was then developed as a simple system to identify genes imme-
diately downstream of RA and demonstrated that RA (but not
T3) has the potential to induce several growth-associated genes.
Thus, the capacity of TH to increase RA synthesis provides a
putative mechanism by which TH may control RA-inducible
genes which may include those that regulate appetite and
growth. Further, it was shown that the RA signalling system in
the hypothalamus is itself partially repressed by an epigenetic
mechanism (histone deacetylation) and can be stimulated by
inhibition of histone deacetylases.
RA has only recently been recognized to be active in the
hypothalamus as a regulatory factor and the hypothalamus is
one of the few brain regions in which RA functions, along-
side regions such as the hippocampus and olfactory system
(Goodman et al., 2012; Hagglund et al., 2006; Shearer et al.,
2012a). However the importance of RA and its precursor,
vitamin A, to control feeding and weight, was recognized
much earlier. The sudden removal of vitamin A from the diet
of rats causes rapid weight loss and a reduction in food intake
which can be countered by administration of RA (Anzano
et al., 1979). Weight loss induced by vitamin A deficiency
(VAD) persists even in force-fed animals, indicating that
VAD affects the fundamental mechanisms of weight control
in addition to regulating feeding behaviour. Further evidence
for the involvement of vitamin A and RA in growth and
energy balance comes from the study of photoperiodic ani-
mals such as hamsters which display increased growth and
feeding under long day (summer-like) conditions compared
to short (winter-like) daylength. Many components of the RA
signalling pathway are upregulated in the hypothalamus of
long day-acclimatized rodents including the retinoic X recep-
tor (RXR) which can heterodimerize with either the TH
receptor or the RA related receptor (Helfer et al., 2012; Ross
et al., 2005; Ross et al., 2004; Shearer et al., 2010; Shearer
et al., 2012b). Finally, the importance of Raldh1 in energy
balance is highlighted in the finding that Raldh12/2 mice are
highly resistant to diet-induced obesity (Ziouzenkova et al.,
2007). This phenotype was ascribed to an excess of retinalde-
hyde in adipose tissue due to a lack of Raldh1. However,
more recent studies have identified Raldh1 as the only
RA-synthesizing enzyme in the mouse hypothalamus (Helfer
et al., 2012; Shearer et al., 2010) and therefore the downreg-
ulation of hypothalamic RA signalling in Raldh12/2 mice
may also play a role in prevention of obesity.
The data presented in this study suggest that TH signal-
ling has the potential to lie upstream of RA in the hypothala-
mus, as T3 upregulated Raldh1 expression both in vivo and ex
vivo. This is consistent with previous observations in VAD rats.
Expression of both TRs and RARs is suppressed in the brain
of VAD rats (Husson et al., 2003). Injecting VAD rats with
RA only reactivated RA signalling, but T3 administration reac-
tivates RAR and TR expression, suggesting that RA signalling
can lie downstream of TH signalling in the brain. In the hypo-
thalamus, RA is synthesized by tanycytes, the only cells in the
hypothalamus that express both Dio2 and Raldh1, with Dio2
synthesizing T3, which can then act to induce Raldh1 and
increase levels of RA potentially to act on both tanycytes and
neurons. This proposed pathway is illustrated in Figure 8. This
system is notable for the very rapid induction of Raldh1 tran-
script. Raldh1 protein is transported along the length of the
tanycyte fibres (Shearer et al., 2010), which have been shown
to contact Agrp/Npy neurons in the hypothalamus (Coppola
et al., 2007), potentially releasing RA immediately adjacent to
the target cells. This novel pathway provides a new route by
which TH may promote expression of neuronal Agrp to
increase appetite (Varela et al., 2012) and may also provide a
mechanism by which TH could increase Ghrh to promote
growth (Ross et al., 2011). The potential also exists for this to
be a mechanism by which TH controls neurogenesis given the
recent finding of RA’s control of cell proliferation in the neuro-
genic regions of the hypothalamus (Shearer et al., 2012b). b2-
tanycytes have been proposed as a neural stem cell population
(Lee et al., 2012) and express Fgf10 (Haan et al., 2013). This
potentially influences the birth of new neurons that modulate
hypothalamic control of energy balance (Kokoeva et al., 2005;
Lee et al., 2012; McNay et al., 2012).
The action of Raldh1 as a downstream effector of TH
was recently described in the developing mouse cerebral cor-
tex (Gil-Ibanez et al., 2014). Our own analysis of the mouse
Raldh1 promoter identified a putative TRE, similar to the
rat. Further, non-verified gene array analysis of hypothyroid
rats, 24 hours after TH treatment, identified Raldh1 as a
putative TH-inducible gene in the hypothalamus (Barrett
et al., 2014). This same gene array analysis also identified
two other unverified retinoid-related genes potentially down-
stream of TH; the first Dhrs7c (dehydrogenase/reductase SDR
family member 7C, SRP-35) which synthesizes retinaldehyde
from vitamin A, the substrate of Raldh1 (Treves et al., 2012).
Also putatively identified to be strongly induced by TH was
Rpe65, a retinoid isomerase (Kiser and Palczewski, 2010).
This study did not show an effect of T3 or RA on Npy/
Cart expression. However Npy is presumed to be downstream
of TH given that it is upregulated in hyperthyroid animals
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(Lopez et al., 2010). Hence, there must be alternative regulatory
pathways downstream of TH signalling that control NPY, either
in the hypothalamus, or extrahypothalamic. Other signalling
routes may also exist for TH regulation of Agrp, as recently sug-
gested to involve mTOR (Varela et al., 2012), but such pathways
may set up long-term changes in contrast to the rapid action of
TH to induce Raldh1. That RA was found to result in a slight
increase in Pomc expression was unexpected given that Agrp was
increased and these factors usually display reciprocal changes.
Pomc expression is known to be regulated by RA in the pituitary
(Paez-Pereda et al., 2001) and protein expression of adrenocorti-
cotropic hormone (ACTH), a product of POMC, appeared
increased by RA in organotypic cultures of mouse hypothalamus
(Shearer et al., 2010). There are instances in which Pomc and
Agrp are simultaneously increased in the hypothalamus, in condi-
tions where both TH and RA signalling are increased (Ross
et al., 2009). Further, there is some evidence that NPY suppresses
Pomc expression via the Y2 NPY receptor (Garcia de Yebenes
et al., 1995) and in vivo NPY may be capable of opposing the
transcriptional activation of Pomc by RA.
Some, but not all, of the RA-regulated genes in the
hypothalamus were subject to regulation by epigenetic modi-
fications. Epigenetic control of gene expression via histone
acetylation has been previously shown to mediate, in part,
some of the effects of environmental influences on the brain
(reviewed by Fagiolini et al., 2009), including alteration of
energy balance. For example, changes in HDAC expression
and histone acetylation have been observed in the ventrome-
dial and paraventricular hypothalamic nuclei of mice that
were either fasted or fed a high-fat diet (Funato et al.,
2011). In addition, epigenetic changes in the foetal hypo-
thalamus caused by maternal stress have been linked to
long-term alterations in energy balance, including suscepti-
bility to diet-induced obesity (Paternain et al., 2012; Stevens
et al., 2010).
These observations suggest that epigenetic modifiers play
an important role in the regulation of metabolic states, particu-
larly in the case of persistent changes over longer timescales.
There is some evidence that the RA signalling pathway is a
major target of HDACIs (Epping et al., 2007). Unliganded
RARa is known to suppress transcription of RA target genes by
recruiting components of the corepressor complex (Hauksdottir
et al., 2003), including HDACs, and HDACIs act partly via
derepression of RA signalling (Epping et al., 2007). The data
presented in this study, in which induction of Rarb and Ghrh
by RA was potentiated in the presence of a class I/II HDACI,
FIGURE 8: A proposed model of retinoic acid function in the hypothalamus. Thyroid hormone circulates in the blood in the form of thy-
roxine (T4) and is taken into hypothalamic tanycytes via transporters such as monocarboxylate transporter 8 (MCT8). T4 is converted by
type II deiodinase (DIO2) to the more active triiodothyronine (T3), which is inactivated by DIO3. Stimuli such as fasting can result in a
local increase in T3 in the tanycytes, upregulating Raldh1 expression. RALDH1 synthesizes retinoic acid (RA), which enters the nucleus
and upregulates expression of target genes via binding to retinoic acid receptors (RAR). Tanycytes project long processes into the
parenchyma which contact hypothalamic neurons and RA may be released immediately adjacent to target cells. Histone deacetylases
(HDAC) may further modulate the action of RA on its target genes. In seasonal animals, the release of thyroid-stimulating hormone
(TSH) from the pars tuberalis of the pituitary (PT) is increased in summer-like, long-day conditions. TSH binds to its receptor (TSHR) on
the surface of tanycytes and increases DIO2 expression while supressing DIO3, and leading to an increase in T3 in the tanycytes. [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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suggests that epigenetic regulation of hypothalamic function
can, in part, act via the RA signalling pathway.
In summary, this study has demonstrated an extra step
of regulatory control in the hypothalamic tanycytes which
provides a mechanism by which TH has the possibility to
control gene expression through sequential nuclear receptor
steps, first the TH receptor followed by the RA receptor.
Such a route may provide an amplification step for TH sig-
nalling. This pathway also provides a point of epigenetic reg-
ulation of hypothalamic function. In the hypothalamus,
HDACs are involved in masculinization of the brain during
the early postnatal period potentially through the nuclear
receptor estrogen receptor a and aromatase (Matsuda et al.,
2011). Control of corticotropin-releasing hormone in the
hypothalamus by the glucocorticoid receptor, another member
of the nuclear receptor superfamily, is potentially mediated by
HDACI (Miller et al., 2011). Epigenetic changes in the
DNA methylation and histone acetylation states of the pro-
moters of hypothalamic genes involved in energy balance,
such as Pomc and Npy, have been found to result from mater-
nal undernutrition or stress (Paternain et al., 2012; Stevens
et al., 2010). This represents a mechanism by which hypo-
thalamic plasticity may be moulded.
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